glutathione pathway to triple negative cancer Targeting Metabolism: Partner in Crime in Anticancer Therapy Targeting the redox-programmed cell death
Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery International Journal of Oncology Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Cysteine metabolic circuitries: druggable targets in cancer British Journal of Cancer
Pay in 4 interest-free payments of $6.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



